Benign neoplasm: Connective and other soft tissue of pelvis

CD2_BENIGN_CONNSOFT_PELVIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D21.5& Hospital discharge: ICD-9 — 2156 Cause of death: ICD-10 — D21.5& Cause of death: ICD-9 — 2156 2 out of 7 registries used, show all original rules.	89
4. Check minimum number of events None	89
5. Include endpoints None	89
6. Filter based on genotype QC (FinnGen only)	89

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D21
Name in latin: Neoplasma benignum textus connectivi pelvis

NAME	CD2_BENIGN_CONNSOFT_PELVIS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D215
HD_ICD_9	2156
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D215
COD_ICD_9	2156
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Connective and other soft tissue of pelvis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Connective and other soft tissue of pelvis

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	614	406	205
Only index persons	554	380	174
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	45.09	45.18	44.60
Only index persons	43.82	44.74	41.82

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	89	63	26
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	46.25	46.74	45.06

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
76: Matched controls
757

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D21.5

ICD-10 Finland

Benign neoplasm: Connective and other soft tissue of pelvis

+∞

97.0

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

8.1

8.0

D48.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue

22.7

7.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

289

2.67

4.90

2.4

2.0

—

(3000492) Spirometry study

2.80

3.30

2.0

1.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

524

2.41

3.04

4.4

3.9

12.1

10.3

mm/h

0.31

478

(3044640) Blood type and Crossmatch panel - Blood

214

2.15

2.95

2.8

2.5

—

(3032080) INR in Blood by Coagulation assay

224

2.12

2.88

5.1

6.2

1.1

inr

0.12

(42870588) Differential panel, method unspecified - Blood

225

2.01

2.51

8.4

6.6

—

(4035726)

2.53

2.40

1.5

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

4.13

2.30

13.4

3.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

157

2.03

2.27

2.7

2.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

242

1.82

1.93

2.0

1.7

96.9

95.6

pmol/l

0.06

112

(3013115) Eosinophils [#/volume] in Blood

359

1.73

1.75

10.0

6.9

0.2

e9/l

0.62

323

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

3.31

1.69

1.0

1.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

344

1.70

1.65

9.9

6.7

28.3

29.4

0.23

327

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

725

2.30

1.56

19.4

12.8

18.1

19.6

mg/l

0.18

548

(3015736) pH of Urine

274

1.68

1.53

3.7

3.3

—

(3013512) EKG study

161

1.77

1.50

2.6

3.5

—

(3022313) Gas panel - Capillary blood

2.85

1.46

4.7

11.0

—

(3028707) Methadone [Presence] in Urine by Screen method

3.25

1.46

1.0

1.9

—

(3035350) Ketones [Presence] in Urine by Test strip

353

1.63

1.43

4.4

3.7

0.0

estimate

—

(3022096) Basophils/100 leukocytes in Blood

317

1.62

1.39

10.6

6.7

0.7

0.17

295

(3021601) Nitrite [Presence] in Urine by Test strip

357

1.60

1.34

5.4

4.9

0.0

estimate

—

(3018010) Neutrophils/100 leukocytes in Blood

339

1.59

1.32

10.1

6.4

56.8

56.0

0.14

323

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.88

1.30

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2.88

1.30

1.4

3.3

10.9

8.7

mg/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

333

1.56

1.24

3.7

4.3

—

(3009261) Glucose [Presence] in Urine by Test strip

362

1.56

1.24

4.4

3.7

0.0

estimate

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

372

1.56

1.23

4.2

4.9

6.2

6.4

mmol/l

0.44

344

(3002256) Pathology report gross observation

1.85

1.20

1.1

1.3

—

(3019069) Monocytes/100 leukocytes in Blood

335

1.55

1.20

10.5

7.1

8.6

8.3

0.29

318

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.15

1.19

1.0

—

(3042936) Bacteria identified in Isolate by Culture

1.79

1.16

2.0

2.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

147

1.66

1.15

3.0

2.0

3.4

3.2

mg/l

0.10

129

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

187

0.53

1.14

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

358

1.52

1.12

10.4

6.6

1.8

1.9

e9/l

0.36

324

(3000764) Benzodiazepines [Presence] in Urine

2.29

1.11

1.0

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2.46

1.10

6.0

11.7

22.5

24.3

mmol/l

—

(3006504) Eosinophils/100 leukocytes in Blood

331

1.51

1.08

10.6

6.6

3.1

2.5

0.73

312

(3027008) Opiates [Presence] in Urine

2.21

1.08

1.0

1.6

—

(3027944) Amphetamines [Presence] in Urine

2.21

1.08

1.0

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

108

1.71

1.06

2.2

3.0

10.0

145.7

ng/l

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

230

1.53

1.05

2.6

3.7

34.5

35.1

ng/l

0.01

128

(3028300) Cannabinoids [Presence] in Urine

2.15

1.05

1.0

1.6

—

(4034850)

2.35

1.04

3.2

6.9

—

(3001604) Monocytes [#/volume] in Blood

343

1.49

1.04

10.7

6.6

0.6

e9/l

0.01

306

(3006315) Basophils [#/volume] in Blood

345

1.48

1.00

10.7

6.6

0.0

e9/l

0.13

308

(3019225) pH of Specimen

1.85

0.98

7.6

3.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

137

1.59

0.95

2.5

2.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

245

1.48

0.92

6.5

3.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.14

0.91

3.5

2.4

—

(3044889) 12 lead EKG panel

459

1.45

0.90

3.4

—

(3018095) Leukocytes [#/volume] in Urine

257

1.45

0.87

5.8

3.7

14.1

54.6

e6/l

2.01

175

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.79

0.87

1.5

4.6

2.4

12.3

ug/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

140

1.55

0.87

1.6

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

123

1.58

0.86

2.2

2.1

—

(3016879) Cocaine [Presence] in Urine

2.00

0.86

1.0

1.6

—

(3023368) Bacteria identified in Blood by Culture

150

1.52

0.83

8.7

4.8

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.80

0.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.78

0.78

1.9

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.64

0.77

4.7

1.5

—

(40761511) CBC panel - Blood by Automated count

773

1.77

0.74

15.1

11.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.06

0.74

2.0

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.98

0.72

1.0

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1.60

0.71

1.9

28.9

28.5

0.19

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.77

0.65

4.6

6.9

—

(3000991) Gas panel - Venous blood

1.69

0.64

7.6

10.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

496

1.35

0.63

7.7

4.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.71

0.62

1.4

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

271

1.35

0.62

5.1

3.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.61

0.0

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.76

0.59

1.3

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

143

1.42

0.59

1.3

1.0

11.0

u/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.61

0.58

2.9

3.5

—

(3026008) Bacteria identified in Urine by Culture

199

1.36

0.56

4.6

2.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

181

1.37

0.55

1.4

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

421

1.30

0.55

12.6

10.8

4.0

3.9

e9/l

0.10

365

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

154

1.39

0.55

1.4

1.9

0.4

1.0

mg/l

1.53

123

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.58

0.54

7.5

10.4

24.1

24.8

mmol/l

—

(3007164) IgA [Mass/volume] in Serum or Plasma

184

1.34

0.50

2.2

1.4

2.0

2.6

g/l

0.75

122

(4010399)

1.57

0.49

2.0

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

540

1.27

0.45

4.1

3.4

—

(3012544) pH of Venous blood

1.50

0.44

6.3

7.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.47

0.44

1.1

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.44

0.43

2.9

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.41

0.0

4.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.41

0.0

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.41

0.0

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1.50

0.41

4.0

10.9

94.7

95.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

778

1.46

0.40

12.5

10.1

26.2

25.6

u/l

0.14

750

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.38

0.39

2.6

1.6

—

(36304419) Bacteria [Presence] in Urine

200

1.27

0.39

5.5

2.7

—

(40768443) Skin Pathology biopsy report

1.41

0.39

1.0

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.37

0.38

2.6

1.8

—

(3019060) Gas panel - Arterial blood

1.50

0.37

2.8

4.1

—

(40761535) Cells panel - Urine sediment

1.39

0.35

8.0

4.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.33

0.34

1.5

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

100

0.67

0.32

1.3

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

111

1.31

0.32

3.5

3.1

8.2

3.8

e6/l

—

(3029937) Albumin [Presence] in Urine by Test strip

188

1.23

0.29

5.6

4.3

0.0

estimate

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

123

1.26

0.27

2.7

2.5

3.5

0.7

e6/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

162

1.22

0.25

4.3

3.7

—

(3022145) Colonoscopy Study observation

1.32

0.25

1.1

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

681

1.21

0.24

15.1

11.6

83.5

87.8

ml/min/173m2

0.73

542

(3020682) Albumin/Creatinine [Ratio] in Urine

182

1.20

0.24

3.3

4.0

1.7

106.5

mg/mmol

0.53

111

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.37

0.24

4.0

9.9

0.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.37

0.24

4.0

10.0

2.1

1.4

—

(3008898) HLA-B27 [Presence]

1.26

0.23

1.0

1.1

—

(1002224) Polysomnography panel

1.26

0.23

1.2

1.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.27

0.22

4.0

2.1

13.3

13.5

umol/l

0.05

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.21

0.0

8.7

—

6.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

3.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

2.4

—

69.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(4306422)

0.00

0.21

0.0

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.21

0.0

1.4

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.1

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.21

0.0

3.4

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.21

0.0

8.2

—

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.00

0.21

0.0

1.0

—

245.0

—

(40758558) Short blood count panel - Blood

194

1.18

0.21

12.4

7.1

—

(40768797) Stomach Pathology biopsy report

1.25

0.21

1.8

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3024928) Oxygen saturation in Venous blood

0.00

0.21

0.0

2.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

3.2

—

(3025941) Bacteria identified in Stool by Culture

1.24

0.20

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.16

0.19

1.5

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

646

0.87

0.19

5.1

4.8

38.7

mmol/mol

0.01

605

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.25

0.18

3.6

2.1

2.4

g/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.17

0.17

2.8

1.8

—

(40761536) Microorganisms panel - Urine sediment

1.17

0.17

6.0

3.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.12

0.16

3.9

2.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

171

0.85

0.16

5.4

6.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

0.74

0.16

5.3

2.9

0.7

0.8

ug/l

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.19

0.16

4.4

2.2

24.2

23.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.14

0.16

2.4

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

103

1.19

0.14

4.3

4.8

18.5

23.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

204

1.10

0.10

4.6

3.1

—

(1761868) Lipid panel - Serum or Plasma

277

0.91

0.10

2.7

2.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

715

0.90

0.09

5.0

4.3

2.8

mmol/l

0.00

666

(36660697) Celiac disease serology panel - Serum

0.85

0.08

1.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.81

0.08

10.0

7.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.03

0.07

1.9

1.6

—

(3000494) Fungus identified in Specimen by Culture

1.13

0.06

1.4

1.3

—

(3012516) Albumin [Mass/volume] in Urine

171

1.07

0.03

3.7

3.1

17.4

41.6

mg/l

1.01

101

(3017143) Hepatitis C virus Ab [Presence] in Serum

108

0.92

0.03

2.1

1.6

—

(3003694) ABO and Rh group [Type] in Blood

228

0.95

0.02

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

703

1.05

0.01

4.4

3.9

1.5

mmol/l

0.02

651

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

154

1.05

0.00

1.4

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

695

1.03

0.00

20.7

12.7

39.5

40.4

0.39

555

(3019832) Treponema pallidum Ab [Presence] in Serum

105

1.05

0.00

1.4

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

4.0

—

107.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

4.0

—

4.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

4.0

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.4

—

(4146454)

0.00

0.0

2.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.5

—

(4268621)

0.00

0.0

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

0.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

1.3

—

13.4

—

(3006462) Nitrate [Presence] in Urine

0.00

0.0

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.0

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

2.5

—

(3045716) Anion gap in Serum or Plasma

0.00

0.0

1.2

—

7.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.0

1.0

—

(3011648) Oxygen content in Venous blood

0.00

0.0

2.3

—

12.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.0

1.0

—

247.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

12.4

—

(4027681)

0.00

0.0

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

3.5

—

30.7

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3017569) Oxygen content in Arterial blood

0.00

0.0

1.4

—

(21494755) Public health laboratory ask at order entry panel

0.89

0.00

1.9

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.0

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

11.8

—

1548.9

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

104.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

5.7

—

75.4

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3016038) Potassium [Moles/volume] in Urine

0.00

0.0

3.4

—

32.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.6

—

(4211845)

0.00

0.0

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

0.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

94.1

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.0

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

9.9

—

836.9

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CONNSOFT_PELVIS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CONNSOFT_PELVIS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CONNSOFT_PELVIS – Benign neoplasm: Connective and other soft tissue of pelvis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Connective and other soft tissue of pelvis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints